Clinical epidemiology and community medicine
- American Gastroenterology Association issues guidelines... // American Family Physician;6/1/1997, Vol. 55 Issue 8, p2860
Presents guidelines issued by the American Gastroenterology Association (AGA) for colorectal cancer screening and surveillance published in `Gastroenterology,' dated February, 1997. Findings of the panel from the literature review of the guidelines; Several recommendations for screening person...
- Molecular Markers May Improve Colon Cancer Staging, Screening. McCann, Jean // JNCI: Journal of the National Cancer Institute;07/05/2000, Vol. 92 Issue 13, p1039
Reports on how molecular markers can help in improving the screening and staging of colon cancer. Problem of understaging in colon cancer patients; Statements of Anton Bilchik, assistant director of surgical oncology at John Wayne Cancer Institute in Santa Monica, California, on the possible...
- Colon cells for cancer screening. Nair, Padmanabhan P. // Agricultural Research;Oct98, Vol. 46 Issue 10, p23
Discusses a technique for early diagnosis of colorectal cancer based on the isolation of live colon cells from stool samples. Background information on colon cancer; Details on the diagnostic method; How it was discovered by a scientist at the Agricultural Research Service of the United States...
- Closely Screen Relatives of Sporadic Colorectal Cancer Patients. // Modern Medicine;Oct98, Vol. 66 Issue 10, p12
Discusses the abstract of the article `Colonoscopic screening in first-degree relatives of patients with `sporadic' colorectal cancer: A case control study,' by A. Pariente, C. Milan et al, published in the July 1998 issue of the `Gastroenterology' periodical.
- Surveillance after positive and negative colonoscopy examinations: issues, yields, and use. Schoen, Robert E. // American Journal of Gastroenterology;Jun2003, Vol. 98 Issue 6, p1237
As colorectal cancer screening gains acceptance by the public, the use of colonoscopy will increase. The frequency of surveillance examinations after detection of an adenoma is one of the largest contributors to the cost of colorectal cancer screening. Ten years after the publication of the...
- Is there a true “shift” to the right colon in the incidence of colorectal cancer? Rabeneck, Linda; Davila, Jessica A.; El-Serag, Hashem B. // American Journal of Gastroenterology;Jun2003, Vol. 98 Issue 6, p1400
: ObjectivePrevious studies have reported a migration in the occurrence of colorectal cancer (CRC) toward a proximal colonic location. To assess the potential impact of this, we evaluated recent temporal trends in the United States.: MethodsUsing the nine population-based cancer registries that...
- Parathyroid hormone-related protein expression in the human colon: Immunohistochemical evaluation. Malakouti, S.; Asadi, F.K. // American Surgeon;Jul1996, Vol. 62 Issue 7, p540
Evaluates the expression of parathyroid hormone-related protein (PTHrP) by immunohistochemical staining in tissue samples from normal colorectal mucosa, polyps and colorectal carcinoma removed from the same patients. Use of commercially available monoclonal antibody; Enhancement of PTHrP...
- Checking in on colon cancer. // Health (Time Inc. Health);Sep93, Vol. 7 Issue 5, p16
Presents a study on frequency of visits needed in the diagnosis of colon cancer. Rate of regrowth of small fingerlike projections called polyps which can grow into tumors; Advice.
- Flexible sigmoidoscopy: Screening for colorectal cancer. JOHNSON, BRETT ANDREW // American Family Physician;1/15/1999, Vol. 59 Issue 2, p313
Discusses the clinical significance of flexible sigmoidoscopy used in the diagnosis of colorectal cancer. Diagnostic preparations; Common complications of the procedure; Techniques in colon visualization.
- Screening for asymptomatic colorectal cancer. Mulcahy, Hugh E.; Farthing, Michael J. G. // BMJ: British Medical Journal (International Edition);1/25/97, Vol. 314 Issue 7076, p285
Evaluates screening for asymptomatic colorectal cancer. Case-control studies; Inherited colorectal cancer syndromes; Criteria foe screening high risk population; Fecal occult blood testing. INSET: Summary points..